Clinical Trials Logo

Respiratory Sounds clinical trials

View clinical trials related to Respiratory Sounds.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02758990 Terminated - Obesity Clinical Trials

Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application

Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to study interactions between genes, lifestyle environmental factors like foods, nutritional supplements and non-invasive medical devices and health factors that can be measured without specialized medical equipment in order to develop lifestyle recommendations tailored to individual genetics for a host of common chronic health conditions.

NCT ID: NCT02269761 Terminated - Dyspnea Clinical Trials

Chest Ultrasound of ER Patients With Cough or SOB

Start date: September 2014
Phase:
Study type: Observational

Acute dyspnea (shortness of breath) is a common complaint for patients presenting to the Emergency Department (ED). The chest radiograph (CXR) has been the mainstay in evaluating patients with shortness of breath and often provides the timely diagnosis of pneumonia, pneumothorax, pulmonary edema, among other primary diseases of the lung. There are limitations with chest radiograph such as large body mass (e.g, obesity) and patient positioning. On occasion, chest radiography findings are difficult to interpret. Lung ultrasonography may offer a means of clarifying ambiguous results. The objective of this study to determine the usefulness of point of care lung ultrasound in evaluating patients presenting to the ED with shortness of breath, cough and/or wheezing.

NCT ID: NCT00962299 Terminated - Dyspnea Clinical Trials

Effectiveness of Inhaled Corticosteroids in Preschool Children With Acute Dyspnea and Wheeze

ICS@ADP
Start date: May 2010
Phase: Phase 4
Study type: Interventional

The aim of the study is to investigate whether inhaled corticosteroids after a first hospital admission for acute dyspnea and wheeze is effective in reducing subsequent episodes of these complaints in children aged 1 to 4 years.